Fight Against Diabetes Advances, Thanks to LSU Agricultural Center Researchers
The Food and Drug Administration has approved a qualified health claim for products containing high-amylose maize starch, which cites its effectiveness in reducing the risk of Type 2 diabetes. The starch was tested for health benefits with the help of researchers from the Agricultural Center at Louisiana State University.
Along with his colleagues, Professor Michael Keenan of the LSU AgCenter School of Nutrition and Food Sciences has been working with the starch for about 15 years. With a qualified claim from the FDA, food marketers are now allowed to promote the diabetes risk reduction benefits of the starch, if it is found in their products, and help improve blood glucose control among the public.
Read more about how researchers are attempting to reduce the risk of diabetes here.